Hospital admissions resulting from preventable adverse drug reactions

BACKGROUND: Adverse drug reactions (ADRs) are a significant cause of hospital admissions. These events can lead to significant morbidity and mortality and financial costs. ADRs that may be preventable might be considered a form of medication error. OBJECTIVE: To assess the potential preventability of ADRs directly related to a patient's hospital admission. METHODS: A retrospective chart review of 437 ADRs occurring during an 11-month period was conducted at a university hospital. A subset of these events leading to hospital admissions was identified for further review. Those that resulted in admission were further examined to determine probability of causality, severity, and preventability. RESULTS: Over 11 months, 158 ADRs were directly related to hospital admission. The relationship of these admissions to drug exposure was determined to be probable or highly probable in 154 (97.4%) of these cases. From this group, 96 (62.3%) of these events were considered potentially preventable, with 23 (24%) considered severe to life-threatening. Characteristics associated with these ADRs included documentation of a toxic drug concentration or abnormal laboratory value (80%), inadequate monitoring of a patient's drug therapy (67%), inappropriate dose (51%), patient noncompliance (33%), drug-drug interaction (26%), contraindication to therapy (3%), and documented allergy (1%). These ADRs resulted in 595 hospital days, with an average length of stay of 6.1 days. CONCLUSIONS: ADRs leading to hospital admissions are often preventable. Approximately 25% of these events were serious to life-threatening. Most resulted from inadequate monitoring of therapy or inappropriate dosing. Patient noncompliance and drug interactions were also common causes. Multidisciplinary prevention strategies among physicians, pharmacists, other healthcare professionals, and patients focusing on communication and education should be targeted.

This article has been cited by other articles:

				C. Kongkaew, P. R Noyce, and D. M Ashcroft Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies Ann. Pharmacother., July 1, 2008; 42(7): 1017 - 1025. [Abstract] [Full Text] [PDF]

				M. S. GOODWIN, W. F. VELICER, and S. S. INTILLE Telemetric monitoring in the behavior sciences Behav Res Methods, February 1, 2008; 40(1): 328 - 341. [Abstract] [PDF]

				N. Wride, T. Finch, T. Rapley, T. Moreira, C. May, and S. Fraser What's in a name? Medication terms: what they mean and when to use them Br. J. Ophthalmol., November 1, 2007; 91(11): 1422 - 1424. [Full Text] [PDF]

				L. A. Thomsen, A. G Winterstein, B. Sondergaard, L. S. Haugbolle, and A. Melander Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory Care Ann. Pharmacother., September 1, 2007; 41(9): 1411 - 1426. [Abstract] [Full Text] [PDF]

				E. Krynetskiy and P. McDonnell Building Individualized Medicine: Prevention of Adverse Reactions to Warfarin Therapy J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 427 - 434. [Abstract] [Full Text] [PDF]

				E. Manias, K. Claydon-Platt, G. J McColl, T. K Bucknall, and C. A Brand Managing Complex Medication Regimens: Perspectives of Consumers with Osteoarthritis and Healthcare Professionals Ann. Pharmacother., May 1, 2007; 41(5): 764 - 771. [Abstract] [Full Text] [PDF]

				D. M. Tarn, J. Heritage, D. A. Paterniti, R. D. Hays, R. L. Kravitz, and N. S. Wenger Physician communication when prescribing new medications. Arch Intern Med, September 25, 2006; 166(17): 1855 - 1862. [Abstract] [Full Text] [PDF]

				E. A van Dijk, N. R. Drabbe, M. Kruijtbosch, and P. A. De Smet Drug Dosage Adjustments According to Renal Function at Hospital Discharge Ann. Pharmacother., July 1, 2006; 40(7): 1254 - 1260. [Abstract] [Full Text] [PDF]

				A. I. Neugut, M. Matasar, X. Wang, R. McBride, J. S. Jacobson, W.-Y. Tsai, V. R. Grann, and D. L. Hershman Duration of Adjuvant Chemotherapy for Colon Cancer and Survival Among the Elderly J. Clin. Oncol., May 20, 2006; 24(15): 2368 - 2375. [Abstract] [Full Text] [PDF]

				S. L Gray, P. S Odegard, A. E. Sales, H. M Young, J. H Sullivan, and S. C Hedrick Quality of Medication Records and Use of Pharmacy Resources in Community Residential Care Facilities Ann. Pharmacother., May 1, 2006; 40(5): 894 - 899. [Abstract] [Full Text] [PDF]

				J. L Yee, N. K Hasson, and D. H Schreiber Drug-Related Emergency Department Visits in an Elderly Veteran Population Ann. Pharmacother., December 1, 2005; 39(12): 1990 - 1994. [Abstract] [Full Text] [PDF]

				S. T. McIntosh and J. B. Petropoulos Using data from automated dispensing units to identify adverse drug reactions Am. J. Health Syst. Pharm., November 15, 2005; 62(22): 2397 - 2400. [Full Text] [PDF]

				P. J. Zed Drug-Related Visits to the Emergency Department Journal of Pharmacy Practice, October 1, 2005; 18(5): 329 - 335. [Abstract] [PDF]

				D. M. Triller, S. L. Clause, and R. A. Hamilton Risk of adverse drug events by patient destination after hospital discharge Am. J. Health Syst. Pharm., September 15, 2005; 62(18): 1883 - 1889. [Abstract] [Full Text] [PDF]

				L. Osterberg and T. Blaschke Adherence to Medication N. Engl. J. Med., August 4, 2005; 353(5): 487 - 497. [Full Text] [PDF]

				T. Morera, G. Gervasini, J. A Carrillo, and J. Benitez Using a Computerized Drug Prescription Screening System to Trace Drug Interactions in an Outpatient Setting Ann. Pharmacother., July 1, 2004; 38(7): 1301 - 1306. [Abstract] [Full Text] [PDF]

				S. M Borcherding Preventing Medication Errors and Improving Drug Therapy Outcomes: A Management Systems Approach Ann. Pharmacother., December 1, 2003; 37(12): 1921 - 1922. [Full Text] [PDF]

				A. H Mutnick, V. Enne, and R. N Jones Linezolid Resistance Since 2001: SENTRY Antimicrobial Surveillance Program Ann. Pharmacother., June 1, 2003; 37(6): 769 - 774. [Abstract] [Full Text] [PDF]

				P. M Lau, K. Stewart, and M. J Dooley Comment: hospital admissions resulting from preventable adverse drug reactions Ann. Pharmacother., February 1, 2003; 37(2): 303 - 304. [Full Text] [PDF]